• Mon news: Novartis in $745M radiopharma pact. Novo launches Wegovy in China. COVID-era telehealth prescribing extended. Hims & Hers GLP-1 tracker. Promising Gilead liver disease trial. See more on our front page

Howz ur raise compared to Kenny's?

anonymous

Guest
Kenny got a 19% raise last year - how's yours compare? And while we're at it, how's that pension switch working out for you too?

Loyalty pays: Merck CEO Ken Frazier scores 19% raise as he stays past retirement age

The BOD gave him a big raise, in part to cover the pension he would have collected if he'd retired on time. Frazier’s total compensation for 2018 was $20.9 million, up from $17.6 million in 2017, making him the third-highest-paid Big Pharma executive as ranked by proxy statements filed so far this year.